Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care

Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care

The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its integration into clinical workflows in real‐world sett...

Full description

Bibliographic Details
Main Authors: Maren Hedtke, Rodrigo Pessoa Rejas, Matthias F. Froelich, Volker Ast, Angelika Duda, Laura Mirbach, Victor Costina, Uwe M. Martens, Ralf‐Dieter Hofheinz, Michael Neumaier, Verena Haselmann
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Molecular Oncology
Subjects:
colorectal cancer
ctDNA
liquid biopsy
liquid profiling
real‐world
Online Access:https://doi.org/10.1002/1878-0261.13156

Internet

https://doi.org/10.1002/1878-0261.13156

Similar Items